Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006104,
umls-concept:C0022614,
umls-concept:C0032105,
umls-concept:C0032743,
umls-concept:C0086045,
umls-concept:C0178602,
umls-concept:C0439849,
umls-concept:C0444706,
umls-concept:C0445223,
umls-concept:C0927232,
umls-concept:C1280500,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1708335
|
pubmed:issue |
2
|
pubmed:dateCreated |
1995-9-25
|
pubmed:abstractText |
Plasma concentrations, maximum regional brain concentrations, and specific regional binding in the brain after administration of 0, 0.1, and 0.2 mg/kg doses of (S)-ketamine were measured in a randomized, double-blind, crossover study in five volunteers and were related to induced effects such as analgesia, amnesia, and mood changes. Specific binding in the brain was assessed by simultaneous administration of (S)-[N-methyl-11C]ketamine quantified by positron emission tomography. High radioactivities in the brain corresponded to regional distribution of N-methyl-D-aspartate receptor complexes. A significant and dose-dependent reduction of binding was measured as a result of displacement of (S)-[N-methyl-11C]ketamine. Memory impairment and psychotomimetic effects were related to dose, plasma concentration 4 minutes after administration, and decreased regional binding of (S)-ketamine in the brain and were consistently seen at plasma and maximum regional brain (S)-ketamine concentrations higher than 70 and 500 ng/ml, respectively. The magnitude of specific binding of (S)-ketamine, measured with positron emission tomography, can be related directly to drug effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0009-9236
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
165-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7648766-Adult,
pubmed-meshheading:7648766-Affect,
pubmed-meshheading:7648766-Brain,
pubmed-meshheading:7648766-Cross-Over Studies,
pubmed-meshheading:7648766-Dose-Response Relationship, Drug,
pubmed-meshheading:7648766-Double-Blind Method,
pubmed-meshheading:7648766-Humans,
pubmed-meshheading:7648766-Ketamine,
pubmed-meshheading:7648766-Male,
pubmed-meshheading:7648766-Memory,
pubmed-meshheading:7648766-Middle Aged,
pubmed-meshheading:7648766-Pain,
pubmed-meshheading:7648766-Reference Values,
pubmed-meshheading:7648766-Tissue Distribution,
pubmed-meshheading:7648766-Tomography, Emission-Computed
|
pubmed:year |
1995
|
pubmed:articleTitle |
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers.
|
pubmed:affiliation |
Uppsala University PET Centre, University Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|